Advances of NSABP breast cancer trails in the past decade
10.3760/cma.j.issn.1673-422X.2017.07.018
- VernacularTitle:NSABP近十年乳腺癌临床试验进展
- Author:
Jiefeng HUANG
;
Xiaorong LIN
;
Zhiyong WU
- Keywords:
Breast neoplasms;
Surgical procedures;
Adjuvant therapy
- From:
Journal of International Oncology
2017;44(7):547-549
- CountryChina
- Language:Chinese
-
Abstract:
The research findings published by National Surgical Adjuvant Breast and Bowel Project have continued to change the clinical practice of early-stage breast cancer over the past decade.Sentinel lymph node biopsy has become the new surgical operation standard.The aromatase inhibitor adjuvant endocrine therapy cycle has been extended from 5 years to 10 years, which benefits the patients with high risk and reactivity.Chemotherapy combined with trastuzumab has become the standard adjuvant therapy strategy of human epidermal growth factor receptor-2-positive invasive breast cancer.In addition, the research progress is also related to the optimization of the fields including the postoperative adjuvant chemotherapy and neoadjuvant chemotherapy.
